Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.

Hwang DG, Schanzlin DJ, Rotberg MH, Foulks G, Raizman MB; Levofloxacin Bacterial Conjunctivitis Place-controlled Study Group.

Br J Ophthalmol. 2003 Aug;87(8):1004-9.

2.

Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery.

Keating GM.

Drugs. 2009 Jun 18;69(9):1267-86. doi: 10.2165/00003495-200969090-00009. Review.

PMID:
19537841
3.

Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis.

Keating GM.

Drugs. 2011 Jan 1;71(1):89-99. doi: 10.2165/11205840-000000000-00000. Review.

PMID:
21175242
4.

The role of besifloxacin in the treatment of bacterial conjunctivitis.

Mahvan TD, Hornecker JR, Buckley WA, Clark S.

Ann Pharmacother. 2014 May;48(5):616-25. doi: 10.1177/1060028014524175. Epub 2014 Feb 24. Review.

PMID:
24566460
5.

Azithromycin 1.5% ophthalmic solution: in purulent bacterial or trachomatous conjunctivitis.

Garnock-Jones KP.

Drugs. 2012 Feb 12;72(3):361-73. doi: 10.2165/11208580-000000000-00000. Review.

PMID:
22316352
6.
7.

Pediatric conjunctivitis.

LaMattina K, Thompson L.

Dis Mon. 2014 Jun;60(6):231-8. doi: 10.1016/j.disamonth.2014.03.002. Review. No abstract available.

PMID:
24906667
8.

Latest industry information on the safety profile of levofloxacin in the US.

Kahn JB.

Chemotherapy. 2001;47 Suppl 3:32-7; discussion 44-8. Review.

PMID:
11549787

Supplemental Content

Support Center